We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants

Delisted

KTOVW was delisted on the 23rd of November, 2020.

1 hedge funds and large institutions have $55K invested in Kitov Pharma Ltd. Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

588% more capital invested

Capital invested by funds: $8K → $55K (+$47K)

50% less funds holding

Funds holding: 21 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
WPSG
1
Wealth & Pension Services Group
Georgia
$55K +$54.1K +82,000 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
-$7K -11,188 Closed
UBS Group
3
UBS Group
Switzerland
-$1K -1,940 Closed

KTOVW Hedge Fund Activity: Q2 2018 in Review

1 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q2 2018, worth a combined $55K — up 588% from $8K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of KTOVW and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $7K sold.

  • 1 institutional investor held Kitov Pharma Ltd. Warrants (KTOVW) as of Q2 2018, down from 2 in Q1 2018.
  • Funds reported $55K of Kitov Pharma Ltd. Warrants stock for Q2 2018, up 588% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q2 2018 and 2 closed out, a net change of -1 holder.
  • The largest Kitov Pharma Ltd. Warrants seller in Q2 2018 was Susquehanna International Group, an estimated $7K sold.

Based on aggregated 13F filings for Q2 2018.